A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection.
about
Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young childrenRibavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young childrenPharmacological management of acute bronchiolitisRespiratory viruses other than influenza virus: impact and therapeutic advancesInhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road aheadViral Infection in the Development and Progression of Pediatric Acute Respiratory Distress SyndromeThe management of acute bronchitis in childrenInhibitors of foot and mouth disease virus targeting a novel pocket of the RNA-dependent RNA polymeraseRespiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.Challenges and opportunities in developing respiratory syncytial virus therapeuticsRespiratory syncytial virus infection: immune response, immunopathogenesis, and treatmentTreatment of acute bronchiolitis with Chinese herbs.Management of acute bronchiolitisAnalysis of antibiotic use and misuse in children hospitalized with RSV infection.Acute bronchiolitis--recent advances in treatment.Management of infections caused by respiratory syncytial virus.Animal pneumoviruses: molecular genetics and pathogenesis.Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agentsA high-throughput screening strategy to overcome virus instabilityRibavirin in the treatment of SARS: A new trick for an old drug?Respiratory syncytial virus infections.Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis.Antiviral therapy: current concepts and practicesMatrix Metalloproteinase-9 Mediates RSV Infection in Vitro and in Vivo(S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection.Effective inhaled drug administration to mechanically ventilated patients.Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication.Motavizumab for the prevention of respiratory syncytial virus infection in infants.Respiratory syncytial virus prevention and therapy: past, present, and future.Comparison of rapid immunofluorescence procedure with TestPack RSV and Directigen FLU-A for diagnosis of respiratory syncytial virus and influenza A virusRespiratory syncytial virus immune globulin intravenous.Respiratory syncytial virus: not just for kids.Diverse Viruses Require the Calcium Transporter SPCA1 for Maturation and Spread.Role of ECMO in the treatment of respiratory syncytial virus bronchiolitis: a collaborative report.Bronchiolitis. Tribavirin may be helpful.A pilot study of prophylactic aerosolized amphotericin B in patients at risk for prolonged neutropenia.Current perspectives on respiratory syncytial virus infection.The feasibility of conducting clinical trials in infants and children with acute respiratory failure.Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial.Mouse model of respiratory syncytial virus infection to evaluate antiviral activity in vivo.
P2860
Q24235515-25744AF0-0BDB-4D33-AFA3-F9364B149BA4Q24242993-41B6D862-6CFF-4ABC-85AF-DD2511019727Q24650574-1ABD00A2-C3F9-4ECD-B826-9970836901A3Q24655957-45028594-814F-4914-B9A9-64691B05EE9BQ26822988-E3ADC029-8D0F-4773-BCF4-EF6CED2C901BQ28071857-FE6BD713-50B5-468C-AF3A-F73CB7B7C401Q28288887-0AD63AAF-63B2-4F3A-81EF-ECB1C2F50E2DQ28476610-F0DC9993-1FB2-437A-941F-214A1237E278Q30240274-E6FA6C95-F5AF-4E92-BAD9-38683AB76C9CQ30300567-D071E470-0078-4A11-8412-977601C56D3FQ33588916-FA065D01-CCE6-4EF2-92DD-637273F37D8BQ33623241-53997BD6-AAD5-4AF7-AAB7-CA838ADDC0C1Q33625250-64FA8199-2CB9-4AAA-B167-B3817E2A6611Q33686706-A2C80389-FCAA-4143-8DEB-BCC471BE2A46Q33929169-0F8FF553-38B2-4820-B088-C06C9BD847ECQ34300336-9E4A94AB-171B-4D29-8231-403614D8AD71Q34313560-B982FD8D-C4B8-4239-8326-BE93D0EE7DA5Q34465570-C74FA084-D995-413C-8302-AA51222F4FCFQ34729728-D65104E9-0291-410D-9910-393A11B317FAQ34979709-E5EAD4E4-68F7-4826-A7B7-37E4AD674785Q35480437-946FEE54-3AED-4AD7-B6D6-FBCB867FE5DBQ35871250-78E15869-65CB-438B-8FB1-FF09E6359509Q36070394-7FA86FE9-17A9-4B55-B837-6BB639517F10Q36076225-60C26D4C-7EA0-4B45-B585-55D426D99452Q36422466-E5E421DB-FB39-4F7C-9219-09FB82E1A5F6Q36690213-7519641C-3817-4F0A-8BD3-FB2A92085AECQ36914809-BFD9D2DF-9F96-42FF-85B9-9BE4DAA89588Q37599884-9BBAD801-DBDB-4D1F-9711-F3FC51D8528EQ37857806-5AF64F3A-A916-4645-9600-0FB99C2DE3E0Q40007980-4E7296CC-D1F3-4254-9157-1E8EBA79C44AQ41316287-7A821E4A-589F-48A2-8208-F0A78C252988Q41535011-66C3A781-7930-4ED3-B766-2DF28DBCBC0DQ41918000-8AA521D8-3F51-4EE8-BB0F-17D8D1812AF0Q42425870-CE397CC4-EF70-45CB-92A7-C55D9F79A810Q42850831-D0A00AE0-B218-490F-AA32-F3E212E502E6Q43533665-0273A74B-C4DC-4A98-BE61-99BCDBD4C89FQ43732093-CD5708E8-973A-41EE-B20A-C968ACA5DBE1Q43917027-96CD974B-CD9A-4F58-A837-3DB21E287197Q45747450-35209C79-0C10-4A8E-A11E-36414FADCD79Q45748055-77F3B33F-75BD-4662-B78B-3605C23F7B79
P2860
A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
A controlled trial of aerosoli ...... ory syncytial virus infection.
@en
A controlled trial of aerosoli ...... ory syncytial virus infection.
@nl
type
label
A controlled trial of aerosoli ...... ory syncytial virus infection.
@en
A controlled trial of aerosoli ...... ory syncytial virus infection.
@nl
prefLabel
A controlled trial of aerosoli ...... ory syncytial virus infection.
@en
A controlled trial of aerosoli ...... ory syncytial virus infection.
@nl
P2093
P1476
A controlled trial of aerosoli ...... ory syncytial virus infection.
@en
P2093
P356
10.1056/NEJM199107043250105
P407
P577
1991-07-01T00:00:00Z